TELA Bio, Inc. (TELA) News
Follow TELA Bio, Inc. (TELA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
TELA Q3'26 Earnings Preview: EPS Estimate at $0.16 Loss
TELA Bio is scheduled to report Q3'26 results November 10 after market close. Revenue is estimated at $20.00 million and EPS at a loss of $0.16.
EQUITY | Nov 09, 2026, 12:02 PM UTC
M
TELA Bio to Announce Third-Quarter 2026 Results
TELA Bio said it will announce its third-quarter 2026 financial results.
EQUITY | Oct 27, 2026, 08:09 PM UTC
L
TELA Bio Secures Covenant Waiver From Perceptive Credit Lenders for Q3—Q4 2026
TELA Bio entered into a Limited Consent to its existing Credit Agreement to obtain temporary covenant relief. The Administrative Agent and Required Lenders agreed not to test the minimum revenue covenant for the fiscal q
EARNINGS | Sep 29, 2026, 08:16 PM UTC
L
TELA Bio Initiated at Buy by Craig-Hallum
Ratings actions from Benzinga
NEWS | Sep 25, 2026, 04:32 PM UTC
L
TELA Bio shares are trading lower after the company reported worse-than-expected Q2 financial results.
TELA Bio shares are trading lower after the company reported worse-than-expected Q2 financial results.
EARNINGS | Aug 11, 2026, 06:15 PM UTC
M
TELA Bio Appoints Heather Getz CEO
TELA Bio names Heather Getz as CEO and Director
EQUITY | Aug 04, 2026, 11:01 AM UTC
L
TELA Bio to Participate in Conference
TELA Bio attends growth conference
EQUITY | Jul 29, 2026, 08:05 PM UTC